All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Boston Scientific Corp. is taking a deeper dive into the mitral valve space with a $90 million investment and an acquisition option agreement with Millipede Medical Inc. The Santa Rosa, Calif.-based company has developed the Iris transcatheter annuloplasty ring system for the treatment of severe mitral regurgitation.